A consortium of investors led by private equity firm CVC Capital Partners, that includes Singapore state fund Temasek, as well as Vatera Healthcare Partners have bought a controlling stake in pharmaceutical company Alvogen.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
